The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
As a result, Imago will become a subsidiary of Merck.
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
Anandiben Patel, Governor, Uttar Pradesh will inaugurate the two-day celebrations
The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
More women centric initiatives being the need of the hour for holistic development
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
Subscribe To Our Newsletter & Stay Updated
